Medicare Enrolled
Dr. Amit Guttigoli, MD
Cardiovascular Disease · Duncanville, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guttigoli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guttigoli? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guttigoli
Dr. Amit Guttigoli is a cardiovascular disease in Duncanville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Guttigoli performed 4,105 Medicare services across 1,802 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guttigoli received a total of $14,927 from 48 pharmaceutical and/or device companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guttigoli is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 23% volume in TX$ $14,927 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,105
Medicare services
Top 23% in TX for cardiovascular disease
1,802
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 432 | $19 | $90 |
| Remote patient monitoring device, 30 days | 397 | $34 | $128 |
| Remote patient monitoring management, 20 min/month | 395 | $34 | $128 |
| Office visit, established patient (30-39 min) | 360 | $90 | $275 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 305 | $30 | $75 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 298 | $19 | $91 |
| Remote pacemaker monitoring, 90 days | 235 | $21 | $90 |
| EKG interpretation and report | 205 | $6 | $36 |
| Office visit, established patient (20-29 min) | 195 | $64 | $200 |
| Electrocardiogram (EKG), 12-lead | 188 | $11 | $34 |
| Remote pacemaker/defibrillator monitoring, 90 days | 136 | $18 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 132 | $27 | $90 |
| Programming of dual lead pacemaker system | 131 | $27 | $79 |
| Regadenoson injection (Lexiscan) for heart stress test | 96 | $44 | $150 |
| Hospital follow-up visit, high complexity | 80 | $90 | $255 |
| Programming of cardiac rhythm monitor system | 57 | $19 | $125 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $74 | $225 |
| Initial hospital admission, high complexity | 42 | $136 | $410 |
| New patient office visit (45-59 min) | 41 | $125 | $345 |
| Programming of multiple lead implantable defibrillator system | 40 | $46 | $150 |
| Programming of dual lead implantable defibrillator system | 38 | $38 | $110 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 31 | $385 | $1,076 |
| Programming of multiple lead pacemaker system | 29 | $30 | $100 |
| Evaluation of implantable heart and blood vessel monitoring system | 29 | $16 | $100 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $342 | $964 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 24 | $49 | $153 |
| Echocardiogram, transthoracic | 23 | $54 | $232 |
| Ultrasonic guidance for blood vessel access | 21 | $11 | $80 |
| New patient office visit (30-44 min) | 20 | $76 | $230 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 16 | $341 | $943 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 15 | $209 | $565 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $555 | $1,700 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $640 | $1,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.0% high complexity
3.5% medium
76.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,927
Total received (2018-2024)
Avg $2,132/year across 7 years
Top 24% in TX for cardiovascular disease
48
Companies
549
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,314 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$613 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,228
2023$2,279
2022$1,737
2021$1,747
2020$1,025
2019$2,955
2018$2,956
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$3,113
Abbott Laboratories
$1,583
BOSTON SCIENTIFIC CORPORATION
$1,530
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,392
Medtronic Vascular, Inc.
$1,225
Medtronic, Inc.
$898
Janssen Pharmaceuticals, Inc
$485
E.R. Squibb & Sons, L.L.C.
$444
Bardy Diagnostics, Inc.
$443
BIOTRONIK INC.
$440
Novartis Pharmaceuticals Corporation
$315
AstraZeneca Pharmaceuticals LP
$304
PFIZER INC.
$293
Cardiovascular Systems Inc.
$272
CVRx, Inc.
$250
CARDIVA MEDICAL, INC.
$226
Impulse Dynamics (USA) Inc.
$200
Merck Sharp & Dohme LLC
$145
Amgen Inc.
$122
Philips Electronics North America Corporation
$106
Amarin Pharma Inc.
$103
Lexicon Pharmaceuticals, Inc.
$96
SANOFI-AVENTIS U.S. LLC
$93
Edwards Lifesciences Corporation
$89
Astellas Pharma US Inc
$77
Biosense Webster, Inc.
$70
Siemens Medical Solutions USA, Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Kestra Medical Technology Services, Inc.
$44
Lantheus Medical Imaging, Inc.
$38
AtriCure, Inc.
$33
Tactile Systems Technology Inc
$33
Inspire Medical Systems, Inc.
$31
Philips North America LLC
$30
ATRICURE, INC.
$28
Smith & Nephew, Inc.
$27
Kiniksa Pharmaceuticals, Ltd.
$25
Itamar Medical Inc
$20
Actelion Pharmaceuticals US, Inc.
$18
Aziyo Biologics, Inc.
$18
ACIST MEDICAL SYSTEMS, INC.
$15
Chiesi USA, Inc.
$14
Ethicon US, LLC
$14
Merck Sharp & Dohme Corporation
$13
ARALEZ PHARMACEUTICALS US INC.
$12
DAVOL INC.
$12
AngioDynamics, Inc.
$11
Top 3 companies account for 41.7% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (CK4) MCOT · (CK7) Extended Holter · ABSOLUTE PRO · ARISTA AH · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Advisor Catheter · Amplia MRI · Arcalyst · Assure WCD · Azure · BRILINTA · Barostim Neo System · Biograph Horizon-3R · BodyGuardian · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Mapping System · CareLink · Carnation Ambulatory Monitor · Claria MRI · Cobalt · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DERMABOND Portfolio · DIAMONDBACK PERIPHERAL · DYNAGEN · Definity · Diamondback Peripheral · ECM · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · EMBLEM S-ICD ELECTRODE DELIVERY SYSTEM · ENDOTAK · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESPRIT · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FLEXABILITY · FLEXITOUCH · FlexAbility Ablation Catheter · Flexitouch Plus · Fortify Assura · GENERAL TACHY · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL TACHY · GENERAL THERAPIES · General - Brady · General - Therapies · INSPIRE · Inpefa · JANUVIA · JOT DX · KENGREAL · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MERLIN@HOME · MOMENTUM · MULTAQ · Micra · NA · OPSUMIT · OPTIMIZER · Orsiro Mission · PICO · PRADAXA · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RESONATE · REVEAL LINQ · RHYTHMIA · RXI SYSTEMS · Repatha · S ICD · S-ICD System Magnet · SQRX PULSE GENERATOR · SelectSecure · Solia · TACTICATH · TactiCath Quartz CFA Catheter · VANTAGEVIEW · VENASEAL · VERQUVO · VIEWMATE · VIGILANT · Vascepa · Verquvo · ViewMate Intracardiac Echo · Viva · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WORKMATE CLARIS · WatchPATONE · WaveWriter Alpha Prime 16 · XARELTO · ZONTIVITY · ZOOM Wireless Transmitter
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $364 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
278
Per 100K population
10.7
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Guttigoli is a remote & electrophysiology specialist, with above-average Medicare volume (top 23% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Guttigoli experienced with evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days?
Based on Medicare claims data, Dr. Guttigoli performed 432 evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guttigoli receive payments from pharmaceutical companies?
Yes. Dr. Guttigoli received a total of $14,927 from 48 companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guttigoli's costs compare to other cardiovascular diseases in Duncanville?
Dr. Guttigoli's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guttigoli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Duncanville
Browse cardiovascular diseases in Duncanville ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology